Unveiling the link between APOE ε4, environmental factors, and Alzheimer's disease in North Lebanon: A case-control
Mohamed Khaled1, Hadi Al-Jamal1, Dana Matar1
1Faculty of Public Health III, Lebanese University, Tripoli, Lebanon.
Background:
Alzheimer's disease (AD) is a multifactorial and progressive neurodegenerative disorder influenced by a variety of genetic and environmental factors. The apolipoprotein E (APOE) gene is known to have a pivotal impact on disease onset, yet clinical studies on its impact on AD remain scarce in Lebanon.
Objective:
This study investigates the interplay between environmental risk factors, the APOE gene, and AD in North Lebanon.
Methods:
A case-control study was conducted with 136 individuals, including 57 AD patients and 79 normal individuals, among which 55 individuals were verified to be cognitively normal via the Mini-Mental State Examination (MMSE). A comprehensive survey was used to collect data on lifestyle factors, medical history, and other possible diseases and deficiencies. Blood samples were collected from all participants, then their DNA was isolated and stored. Real-time PCR was adopted for genotyping.
Results:
The total APOE ε4 allele prevalence was reduced from 19.1% to 16.1% after MMSE adjustment. Based on the univariate analysis, factors like age, illiteracy, vitamin and iron deficiencies, blood pressure, and chronic diseases were identified as prominent risk factors, while the allele showed no significant correlation with AD. However, in the multivariable analysis, this allele emerged as a key risk factor (p = 0.04). Factors like age ≥ 65, vitamin deficiency, iron deficiency, blood pressure, and other chronic diseases were consistently significant.
Conclusions:
Our results provide significant evidence that the influence of APOE ε4 on AD is governed by several environmental factors such as age, vitamin and iron deficiencies, high blood pressure, and chronic diseases.
More Related Videos
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
